Sinovac Biotech Ltd (SVA) — Cash Flow Reinvestment Rate
Sinovac Biotech Ltd (SVA) has a Cash Flow Reinvestment Rate of 0.36x as of December 2023, reinvesting $52.75 Million (capex $52.75 Million ) from operating cash flow of $146.01 Million. Check SVA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinovac Biotech Ltd Cash Flow Reinvestment Rate (2007–2023)
Historical reinvestment intensity for Sinovac Biotech Ltd across 12 annual periods. Explore long-term investment intensity of Sinovac Biotech Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sinovac Biotech Ltd (2007–2023)
Year-by-year capital reinvestment analysis for Sinovac Biotech Ltd. For live market cap and broader valuation context, see SVA company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 28.96x | $3.07 Billion | $106.02 Million | $145.69 Million | ▲ +11774.8% |
| 2021 | 0.24x | $3.74 Billion | $15.35 Billion | $719.98 Million | ▼ -42.9% |
| 2020 | 0.43x | $204.78 Million | $479.31 Million | $127.65 Million | ▼ -68.6% |
| 2019 | 1.36x | $53.08 Million | $39.07 Million | $10.63 Million | ▼ -65.0% |
| 2018 | 3.89x | $30.87 Million | $7.94 Million | $5.61 Million | ▲ +875.5% |
| 2017 | 0.40x | $23.81 Million | $59.76 Million | $11.91 Million | ▼ -93.3% |
| 2015 | 5.93x | $24.97 Million | $4.21 Million | $5.30 Million | ▲ +544.1% |
| 2013 | 0.92x | $5.13 Million | $5.58 Million | $5.13 Million | ▼ -17.0% |
| 2011 | 1.11x | $15.46 Million | $13.94 Million | $15.46 Million | ▲ +1142.9% |
| 2009 | 0.09x | $4.32 Million | $48.41 Million | $4.32 Million | ▼ -76.4% |
| 2008 | 0.38x | $3.98 Million | $10.50 Million | $3.98 Million | ▼ -33.8% |
| 2007 | 0.57x | $2.47 Million | $4.32 Million | $2.47 Million | — |